From our list 9 new startups in Vienna worth knowing (2026)
Epitome Therapeutics is developing CADENCE, an epigenome editing platform for precise and lasting control of gene expression without changing the DNA sequence, aimed at rare and metabolic diseases. A spin-off from EMBL founded in 2025 by Guido Gualdoni and Jamie Hackett, it announced 4 million euro at launch on 30 June 2026: a 2 million euro pre-seed round led by XISTA Science Ventures and Caesar Ventures, with Navec Venture Holding, plus 2 million euro in grants from aws and FFG. Website: epitome-tx.com. Source: Startup.eu.
Questions about Epitome Therapeutics
What does Epitome Therapeutics do?
Epitome Therapeutics: switching genes on and off without changing DNA.
Where is Epitome Therapeutics based?
Epitome Therapeutics is based in Vienna, Austria.
Where can I read more about Epitome Therapeutics?
Epitome Therapeutics is in our list 9 new startups in Vienna worth knowing (2026): https://meetnewbrands.com/articles/new-startups-in-vienna-2026